Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver.
about
Adeno-associated virus vectors and hematologyGene therapy for the hemophilias.Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver.Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon systemSafety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogs.Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vectorA limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transductionAdeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice.Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells.Assessing the potential for AAV vector genotoxicity in a murine model.Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transferInduction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer.Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectorsThe 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.Adeno-associated virus vectors: potential applications for cancer gene therapy.Ribosomal DNA integrating rAAV-rDNA vectors allow for stable transgene expression.Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality.Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein.Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liverA large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating systemThe Jeremiah Metzger Lecture: gene therapy for inherited disorders: from Christmas disease to Leber's amaurosis.Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice.AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cells.Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice.The complex and evolving story of T cell activation to AAV vector-encoded transgene products.Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia.Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.Lentiviral Based Gene Transduction and Promoter Studies in Human Hematopoietic Stem Cells (hHSCs)Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transferImmune deviation by mucosal antigen administration suppresses gene-transfer-induced inhibitor formation to factor IX.Lessons learned from lung and liver in-vivo gene therapy: implications for the future
P2860
Q33695816-41DE4CB7-18CB-43FA-AFA9-F162FA44D92BQ33723486-10912ED2-863C-4B9F-9336-EBD04E67E4F0Q33802664-D9A18BDC-DE67-45E9-BAE5-07F50227A74BQ33811409-830EDEC6-77BD-4536-8B50-26B24CB47744Q33815070-60AF85F0-4529-4ED1-A57D-D4AD850F4833Q33844362-8121A135-1D09-46B6-A5EB-6634E8119FB1Q33888773-3F7FC0DC-6FD2-4912-988A-FB56F14D3844Q34025098-15D7E263-0EB5-4A7A-8993-7B72618CDE1BQ34059643-CA0F7C76-01C2-45B4-AB04-A5D23A80972AQ34348760-98ADAED8-20DC-4C17-A617-B95A95AE43D2Q34356203-ABDC2886-C60A-4987-986F-52CF330D2207Q34483749-521C3160-AF41-4BC4-B72D-4D4370B1A82AQ34574858-3A387BA4-30E0-4903-83BE-9B69BDF36BD5Q34754355-2718FE42-3463-4428-84DE-236F0385E948Q34870564-C8FF88D1-1AED-4EE7-9344-E0E21719CDABQ34985105-44C76F67-F8F5-49F2-B688-65D8EBC1CAD6Q35085243-F01027EC-80FA-49AF-8E4B-4BA47C0D9601Q35101411-5FD956B1-97E6-4FA4-BC46-012F4A932922Q35157358-1DDFB7E3-B5D5-4486-8594-67B8118DAC2BQ36165834-B7F179E0-BC73-4F86-A4D4-1B2EAB32F2ADQ36298655-B2C6D456-6471-48A2-834D-E5E3BEAF3392Q36454880-04E2668D-FB7D-4951-9082-D269D150405BQ36509889-05EFDBA7-8EA6-4B07-81F7-C6A6FDC49EC9Q36532500-627DE424-5FAE-498C-B0EE-DA68C5635826Q36553907-40C1631D-E96E-4D9E-82D2-47D21878681DQ36898802-FE0F969B-686F-49C5-84BB-33BDD9696FB1Q36984591-F2608FBA-0D00-4CC4-81F4-85FB0A1F1625Q37221688-BA9564DB-678A-4A11-9FA8-A07D66F27679Q37348229-B7B039CA-91D8-40AF-9FE6-9E7EF1007981Q37596958-D5740B3D-A3B7-4FA7-8737-1CFD2CD6AEA9Q37690441-0221E795-61FB-4810-A7B9-6D05DC0A33BFQ37690491-6E746A03-B7EB-4FE3-8057-30EFD68A569FQ37747148-D6612B37-2C09-41DA-BC81-B8AA0CEDC1FBQ37814051-40FD7E5E-EAE8-4BE1-A32D-6739F729A1C8Q39553052-A5B53330-8813-4802-8BB3-B2C7AFFD3DE2Q40121209-4AC23153-E333-4646-8F74-8F35D3F17E12Q41787097-C85BB03C-77BB-426E-AD04-85E6E34DAB54Q41920883-29DC31A7-FF0F-4852-AF31-43E95C26FC69Q42183295-70038B09-7CCD-435B-BDCD-E42CBD4D0581Q57163666-F5E23C12-16A8-4142-AC19-E902819D34A5
P2860
Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Adeno-associated viral vector- ...... on factor IX into mouse liver.
@en
Adeno-associated viral vector- ...... on factor IX into mouse liver.
@nl
type
label
Adeno-associated viral vector- ...... on factor IX into mouse liver.
@en
Adeno-associated viral vector- ...... on factor IX into mouse liver.
@nl
prefLabel
Adeno-associated viral vector- ...... on factor IX into mouse liver.
@en
Adeno-associated viral vector- ...... on factor IX into mouse liver.
@nl
P2093
P1433
P1476
Adeno-associated viral vector- ...... on factor IX into mouse liver.
@en
P2093
Hagstrom JN
Kurtzman GJ
P304
P407
P577
1998-06-01T00:00:00Z